Pharmaceuticals

Ascletis Received IND Approval and Management Outlook of 2019 and Beyond

HANGZHOU and SHAOXING, China, Aug. 5, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it received I...

2019-08-05 08:00 3567

CPhI & P-MEC China 2019 celebrated its 19th edition as a great success

SHANGHAI, Aug. 2, 2019 /PRNewswire/ -- Successfully concluded at Shanghai New International Expo Centre (SNIEC) onJune 20, 2019, CPhI & P-MEC China 2019 achieved its goals of displaying new achievements, igniting collision of new ideas, and out-looking on new trends in the three days and received...

2019-08-02 12:39 2790

I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors

SHANGHAI and SAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China and U.S.-based clinical stage biopharmaceutical company exclusively focused on the discovery and development of potential first-in-class and best-in-class biologics in immuno-oncology and autoimmune diseases, an...

2019-08-01 20:06 2335

111 to Announce Second Quarter 2019 Unaudited Financial Results on August 15, 2019

SHANGHAI, Aug. 1, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the second quarter endedJune 30, 2019, before U.S. markets open o...

2019-08-01 20:00 6354

Marken Acquires Japanese Logistics Company

Acquisition of PCX Expands the Company's Footprint in Japan RESEARCH TRIANGLE PARK, North Carolina, Aug. 1, 2019 /PRNewswire/ -- Marken announced today the acquisition of PCX International Co. Ltd based in Japan.  PCX operates from theirTokyo headquarters to coordinate the delivery of over 3,0...

2019-08-01 18:00 3490

ERBA Mannheim to Unveil NEXUS Next Generation Automation at AACC 2019

LONDON, Aug.1, 2019 /PRNewswire/ -- * New affordable, modular, mid-scale clinical chemistry, immunoassay and hematology range with sample selection and transport systems, making powerful automation accessible to growing labs * Hematology system uses unique combination of ultra-high defi...

2019-08-01 04:39 1971

MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine

MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon's entire portfolio of assets inGreater China ST. LOUIS, July 31, 2019 /PRNewswire/ -- MediBeacon Inc., whose largest shareholder is Pansend Life Sciences, LLC, a subsidiary of HC2 Holdings, Inc. ...

2019-07-31 20:30 3724

Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal

INCHEON, South Korea, July 31, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy, pending regulatory approvals. UCB's anti-tau candi...

2019-07-31 19:00 1686

GC Pharma Reports Q2 2019 Results

YONGIN, South Korea, July 30, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months endedJune 30, 2019. Key Figures Q2 2019(1) Growth(1) Total revenues KRW 35...

2019-07-30 22:31 7892

Scala and FUTURAMEDIA Drive French Pharmacy Sales with Digital Signage

Point of sale and street-facing Scala-driven digital signage screens increase product sales by up to 80% in thousands of pharmacies acrossFrance SITTARD, The Netherlands, July 30, 2019 /PRNewswire/ -- Scala, part of the STRATACACHE family of digital media/marketing technology companies, has been ...

2019-07-30 17:00 1382

HKSH Medical Group Brings Precision Radiation Medicine to Cancer Patients in Asia With Elekta Unity MR-Linac

HONG KONG, July 30, 2019 /PRNewswire/ -- Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalized precision radiation therapy, is in clinical use at HKSH Cancer Centre. The milestone marks the first clinical use of Elekta Unity inAsia. HKSH rec...

2019-07-30 13:47 6044

Internationally Renowned Radiation Oncologist, Prof. Dr. Dattatreyudu Nori Appointed as International Director, Apollo Cancer Centres, Apollo Hospitals Group

NEW DELHI, July 29, 2019 /PRNewswire/ -- Apollo Hospitals have appointed world renowned Radiation Oncologist, Prof. Dr. Dattatreyudu Nori, as International Director – Apollo Cancer Centres, Apollo Hospitals Group. Beginning this month, Dr. Nori will be available for consultations 10 times at Apol...

2019-07-29 22:17 3512

Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution

SHANGHAI, July 29, 2019 /PRNewswire/ -- 3SBio Inc. (01530.HK), a leading biopharmaceutical company in the PRC, announces today that an application for the production of new drug has been submitted to the National Medical Products Administration for Yisaipu® pre-filled aqueous injection solution (...

2019-07-29 21:42 5489

Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets

REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today ...

2019-07-29 12:00 5594

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...

2019-07-28 21:47 5636

China Biologic Products to Report Second Quarter 2019 Financial Results

BEIJING, July 26, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2019 financial resu...

2019-07-27 04:30 10364

Sanofi Announces Participation in 2nd China International Import Expo

SHANGHAI, July 26, 2019 /PRNewswire/ -- At today's Matchmaking Meeting for Medical Devices and Medical Health Care Exhibitors and Buyers of the 2nd China International Import Expo (CIIE), Sanofi officially announced that it would participate in the 2nd CIIE held in the National Convention and Exh...

2019-07-26 21:50 3804

Novartis, Mundipharma ink partnership to enhance access to three Asian countries to established medicine brands for glaucoma and external eye diseases

* Novartis and Mundipharma have signed an agreement for Mundipharma to market, sell and distribute Novartis medicines in the general ophthalmology disease area, including medicines for glaucoma and external eye diseases in Taiwan. This follows recent agreements for the Philippines and Thailand. ...

2019-07-26 12:25 2584

Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development

VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biot...

2019-07-25 19:00 3367

First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment

SUZHOU, China, July 25, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announ...

2019-07-25 08:16 3206